chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First dose of vaccine received on 10-FEB-2021 and second on 20-MAR-2021, 38 days apart; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of vaccine received on 10-FEB-2021 and second on 20-MAR-2021, 38 days apart) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Ulcerative colitis (Moderate to severe ulcerative colitis) and Crohn's disease (Moderate to severe adult Crohn's disease).   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of vaccine received on 10-FEB-2021 and second on 20-MAR-2021, 38 days apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of vaccine received on 10-FEB-2021 and second on 20-MAR-2021, 38 days apart) outcome was unknown.            No concomitant medication was reported by reporter.  On 21-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. It was unknown if the patient was enrolled in COVID-19 vaccine trial.  No treatment medication was reported by reporter.   This case was linked to MOD-2022-580234 (Patient Link).
sore jaw temples and numbness and pain throughout body worse in hands and feet.  Achy joints  symptoms have worsened and remain to date .  Diagnosed as small fiber neuropathy
Severe rash; Tiredness; Muscle soreness; Swelling of gums; Hives; Chills; Night sweats; Poor sleep; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Oct2021 at 09:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. It was unknown if the patient had medical history and any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Oct2021, the patient experienced severe rash, tiredness, muscle soreness, swelling of gums, hives, chills, night sweats and poor sleep. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe rash, tiredness, muscle soreness, swelling of gums, hives, chills, night sweats and poor sleep were not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Swelling and redness first noted on 9/21/00 PM in left posterior arm. Has increased in size and developed a hardened purplish lump at site. Returned to PCP for evaluation.
symptoms started 6 hours after I took the vaccine.  Symptoms included temp of 100.6, headache, malaise, joint aches.  I had covid late May and gave blood, to the agency on December 18th.  Report showed I had antibodies
VARIVAX was administered after the TE.; No reported adverse reactions; This spontaneous report was received from a medical assistant and refers to a patient of a not reported age or gender. The patient's medical history, concurrent conditions  and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #w039294, expiration date: 11-DEC-2024, administered for prophylaxis (strength, dose description, vaccination scheme, anatomical location, and route of administration were not provided) following a temperature excursion (Improper storage of product in use). No reported adverse reactions.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2310USA000653: US-009507513-2310USA000492:
I am currently pregnant with my second child, due on 12/7/21. At 33 weeks+1 I received the Pfizer vaccine. 2 days later I started feeling very sick and getting lots of cramping which I had not felt before, this lasted for 3 days but went away.  The following Friday out of no where my nose started pouring blood (I have not had a bloody nose since I was a child). It took almost 10 minutes to stop. 2 days later, another bloody nose. The second time poured like a faucet and I could not keep up with a paper towel so just kept my head over the sink while it drained. This one did stop in less than 5 minutes.  I have been monitoring my blood pressure which is usually ver consistent but it is all over the place the past few days. Continuing to monitor nose bleeds and blood pressure. None of which I had with my previous pregnancy.
Patient states she received the flu vaccine on 10/25/00 between 18:00 and 20:00. She states the next evening, she was itching and her mother noticed she had hives on her neck, back, chest, abdomen, arms and legs. She states her face was clear. She didn't seek medical evaluation but took Benadryl, used calamine cream and took oatmeal bathes. No shortness of breath. She states symptoms all gone by 10/30/00. She states she had the vaccine for the past 8 years without problems.
Severe hives all over my body. Shortness of breath, throat tight, fever. I went to the doctor 3 times, I'm still very sick, taking 4 different medicines.
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. T60h21a) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer / BioNTech (Dose Number: 2 Batch/Lot No: Eng198 Location of injection: Arm Right) on 19-Mar-2021. Past adverse reactions to the above products included No adverse event with Pfizer / BioNTech. Concurrent medical conditions included Drug allergy (Unspecified drug).    On 18-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 07-May-2022 to 11-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-May-2022, SARS-CoV-2 test: positive Positive. On an unknown date, SARS-CoV-2 test: negative negative and positive Positive.         Patient did not take any other medications/products within 2 weeks of starting COVID-19 treatment. Patient previously received a COVID-19 Vaccine.   Patient reported that "I took Paxlovid and had rebound Covid-19 five days later".  Company comment- This spontaneous case concerns a patient of unknown age and gender with no relevant medical history, who experienced unexpected, non-serious adverse event of special interest Covid-19 which occurred at an unknown time with regards to the mRNA-1273 vaccination. Patient took paxlovid and had rebound Covid-19 five days later. The outcome of the event was reported as resolved. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a patient of unknown age and gender with no relevant medical history, who experienced unexpected, non-serious adverse event of special interest Covid-19 which occurred at an unknown time with regards to the mRNA-1273 vaccination. Patient took paxlovid and had rebound Covid-19 five days later. The outcome of the event was reported as resolved. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Patient vaccined with dose 2 of Pfizer COVID vaccine.  On 3/16/2021 developed chills, cough, nausea/vomiting, cough, and pharyngitis.  Tested positive for COVID.
I experienced feeling very ill after the shot for 3 days, no appetite, headaches, body ache, fever and tiredness.
Random heart palpitations; This is a spontaneous report from a contactable consumer (patient). A 28-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EL8982,) via an unspecified route of administration in left arm on 22Jan2021 at 12:00 (at the age of 28-years-old) as first dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient did not receive any other vaccine received in four weeks. Patient had not been diagnosed with COVID prior to vaccination and had not been tested for COVID post the vaccination. On 25Jan2021, the patient reported that since receiving his vaccine, he noticed random heart palpitations. They have been less frequent as of recent but some of his coworkers have reported the same thing. They are non painful and happen irregular. Patient did not received the treatments. The outcome of the event was recovering.  Follow-up attempts completed. No further information expected.
Presented with sore throat, cough, SOB x 5 days; Admit to medical with Covid PNA, tx with remdesivir, Vit C, vit D3, steroids, singulair, zinc; minimal supplemental O2; No O2 needed at d/c
Redness upper arm above elbow (left) at edenia (below vaccination site and circumfenential) with urticania.
This case was reported by a nurse via call center representative and described the occurrence of headache in a 18-year-old female patient who received BEXSERO (batch number 165601, expiry date October 2018). Concomitant products included FLUZONE. On 2nd October 2017, the patient received BEXSERO .5 ml. On 3rd October 2017, 1 days after receiving BEXSERO, the patient experienced headache (serious criteria disability) and migraine (serious criteria disability). On an unknown date, the outcome of the headache and migraine were recovering/resolving. The reporter considered the headache and migraine to be related to BEXSERO. Additional details were reported as follows: The patient received BEXSERO in the left deltoid. The patient complained of severe headache after receiving the vaccine. During the same day office visit, the patient concomitantly received FLUZONE in the left deltoid (batch number: 20180630,  expiry date: 30th June 2018). However, the patient thought the headache was result of the BEXSERO. The patient came back into the office for 3 additional follow-up visits after initially receiving the vaccine. On 10th October 2017, the patient came back with an acute visit with complaints of severe pain and migraines which had been ongoing for one week. On 13th October 2017, the patient again returned to the office with still headache for two weeks then. The patient returned again on 16th October 2017 with headache behind eyes and middle of forehead. It was reported that with each visit the pain seemed to be resolving, and the patient was able to return to school at the time of report. No further information was reported regarding the event. Healthcare professional would like a copy of the  Adverse Event report mailed to the facility for their records.
pt seen in ED and dx with AHRF, sepsis due to COVID pneumonia, AKI, thrombocytopenia; started on decadron, pepcid, zofran, IV fluids; admitted to hospital; pt has had cough, congestion, confusion, N/V; pt's condition worsened in the hospital requiring intubation with mechanical ventilation; transferred to ICU; pt experienced cardiac arrest and died in the hospital
Patient called with report of arm swollen after injection and pain in the left arm. Patient was given an immediate appointment. In office patient was assessed Pain, swelling, redness localized to arm vaccine was given in. The Patient was given 50mg of Benadryl when advised to take 25 mg of Benadryl every 4-6hrs and notify us if no improvement.
fever for 5 days, inconsolable crying for 6 days, encephalitic screaming for 6 days
been sick ever since; Initial information received on 28-Oct-2021 regarding an unsolicited valid social media non-serious case received from a consumer/non-health care professional.  This case involves adult and unknown gender patient who experienced been sick ever since (Malaise) after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease, or risk factor.  The patient medical treatment(s), vaccination(s), concomitant medication, and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious been sick every since (malaise) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if there were laboratory data/results available.  It was unknown if the patient experienced any additional symptoms/events.  It was not reported if the patient received any corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
15 minutes after receiving Vaccine, patient started complaining of dry mouth and sweating. Patient denies palpitation, shortness of breath or throat closing. VS:130/84, HR=84 regular, RR=20,Temp:97.5. Patient was observed for 20 more minutes, given water and allowed to rest.    Patient felt better and sent home  with her  mother. Patient recommended to Healthcare provider or call 911 for severe allergic reaction
Originally the nurse reported that "no reactions were observed at present". In follow up, the nurse reported that the patient was "just more clinging to her for a couple of days". The mother thought that he had a 99F temperature, but "did not check it". Additional information is not expected.
Experienced chest discomfort with diaphoresis approximately 5-6 days after immunization. Pain increased with deep breathing with some relief from B-? inhaler. Pt eventually evaluated at the ER-CABG x2. No history or symptoms of cardiac Dz.
At day 8 thru 12 experiencing slight rash, warm to touch, itch and spreading down and under arm from injection site.  Pharmacist said to take Benadryl , use cordazone creme and call doctor if continues to spread or get worse
I woke up at 1:00 a.m. with severe shaking from head to toe.  This caused loss of bladder function.  Hands were ice cold.  This went on for a 1/2 hour.  It happened to me also with the prior booster 3:00 a.m., and the shaking lasted an hour.  My husband also experienced this with his prior booster.  Our family dr. told us to premedicate with Tylenol to avoid this.  I took a Tylenol at 12:00 noon an hour after the booster, but still had this reaction.  I also took a Tylenol at 1:15 a.m., which caused the shaking to subside and calm down.  The shaking is severe and encompassed every fiber of my body.  My breathing was shaky, too, because I tried to take deep breaths.
Large 2 1/2 in wide x 4 in long red, hard, warm, itchy area at injection site both Modern vaccine one and then again the second one.  The second one darker in color but same size.  The second one given 02/25/21 at same place, same arm per my request.  It was a couple days late d/t weather and delivery problems.  Lasted a week with both injections.   I have a pic to verify.
c/o chest pain began 1 day (may 26) after2nd pfizer vaccination (May 25). Patient came to ER on 5/27. C/o chest pain. Physical exam shows chest wall Tenderness to palpation.
Information has been received from a healthcare worker concerning a female patient who in 2009 was vaccinated with three doses of GARDASIL (Lot # not reported). Now, in January 2010, the patient was having joint pain and arm pain. It is unknown if the patient sought medical attention. At the time of the report, the patient  had not recovered. Follow-up information has been received from a healthcare worker concerning the female patient who was vaccinated with GARDASIL. It was reported that the patient was fine. She had some discomfort in her joint and arm where she received the GARDASIL injection that lasted for a few days and subsided without intervention or treatment. The patient was currently recovered and the office felt as though it was "no big deal", as the patient was not even sure if the discomfort was from something she did over the weekend and not even from the injection. Additional information is not expected.
Chemical taste in mouth, then below ear and behind the jaw (left side) there was swelling and went away 3-5 minutes. The taste bothered her most.
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. consulted with the Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working  on a compliance improvement plan and has been reinstated vaccination privileges.
Day time enuresis with later having headaches (frontal headache) and aggressive behavior. Had three episodes of the day time enuresis and two episodes of headaches that self-resolved. Mom did give the first time he had a headache. All symptoms resolved by 9/22/2020. No localized erythema, swelling, calor nor point tenderness from the injection site.
Headache, Myalgia, Arthralgia, NEREVE PAIN TO THE NECK, PAIN AT INJECTION SITE, NASAL STUFFNESS, RUNNY NOSE, SOB, LEFT OVARIAN PAIN Narrative:
ActHib vaccine was involved in a temperature excursion and was advised to be pulled from stock and to not be given. One of the nurses was not aware of the instructions given and administered the vaccine before being notified . Patient did not have any adverse effects/reactions. Sanofei, the vaccine company was contacted and told what happened, the case worker from the vaccine company stated patient would just need to be re-vaccinated. Patient has an appointment to do so.
patient experienced headache for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (patient experienced headache for 24 hours) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included Kidney disorder. Concurrent medical conditions included Diabetes since 1993, Drug allergy and Allergy to chemicals. Concomitant products included DULAGLUTIDE (TRULICITY), INSULIN DETEMIR (LEVEMIR), GLIPIZIDE, METOPROLOL, LOSARTAN, FAMOTIDINE, ASPIRIN [ACETYLSALICYLIC ACID] and ROSUVASTATIN for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced HEADACHE (patient experienced headache for 24 hours). The patient was treated with GABAPENTIN at a dose of 100 microgram three times a day. On 05-Feb-2021, HEADACHE (patient experienced headache for 24 hours) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient has no COVID + test or diagnosis. It was reported that no recent change in status such as improvement or worsening.  It was reported that other no vaccines given within 1 month prior to Moderna COVID-19 vaccine (type, brand, lot, route, dose #). .   This case was linked to MOD-2022-552505, MOD-2022-552517 (Patient Link).
Bruised feeling; Left arm sore; This is a spontaneous report received from a contactable consumer, the patient. A 45-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on the left arm, on 09Mar2021 at 13:00, as a single dose for COVID-19 immunisation (at the age of 45-years-old). Medical history included high blood pressure (controlled with medication). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient received unknown medications within 2 weeks of vaccination. It was reported that the patient was allergic to sulfer, bacterium and avelox. On 09Mar2021 at 15:00, the patient experienced pain in arm. It was reported that the patient took Tylenol for the pain. Patient reported that the left arm was sore for 2 days went away, 5 days later on 14Mar2021 the pain came back bruised feeling and very warm to touch. It was day 11 past injection day and it was still sore. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events pain in arm and bruised feeling was not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Signs of Tourette Syndrome. Sudden and severe tics. Started in his shoulders throwing his head shoulder to shoulder and spitting, stepping in place and jumping around in place while doing all mentioned. His verbal tics are stop. clearing throat and bitch. Other things that came suddenly is head butting people and objects impulsive behavior and OCD. He has to do many things three times. If asked how many times a day this happens I couldn't answer that because its constant non stop every few seconds. It has tremendously changed our lives. He was very healthy before the vaccinations.
On 4/14/2021, I received my second Pfizer vaccination. On 4/15/2021, the right arm was very sore, but I thought nothing of it, as this is often what happens when you get a shot. The pain persisted, however. At the time of this writing, I have intermittent pain in both shoulders around the area where I received my injections for the COVID, pneumonia, and shingles vaccines I received a year ago. The area gets tender and achy. Sometimes both shoulders are affected, and other times it's just one shoulder. Whenever I have pain, I rub on Aspercreme and Aleve Max cream. They help to some extent, but they don't completely alleviate the pain. On account of the timing of the onset of pain, my doctors believe the pain could be attributed to the second COVID shots. I went to an urgent care clinic on 4/12/2022, because the pain in both of my shoulders was so intense and long-lasting that I needed relief. The doctor recommended that I continue using pain relief cream and to take medicines like Tylenol and Motrin.
Ten days post vax the patient experienced a low grade fever and tiredness. On approximately 03/06/2001, the patient developed a rash all over her body. Unspecified medical attention was sought. Additional information has been requested.
A report has been received from a Health Professional concerning a 9 year old, male subject, who has been receiving FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on 29-Nov-2013. It was the patient was administered expired FLUMIST on 29-Nov-2013. Patient had reported any symptoms. The outcome of the event of ADMINISTERED EXPIRED FLUMIST is unknown. The report was considered to be non-serious. Summary of follow-up information received by AstraZeneca/MedImmune on 10-Dec-2013 from Health Professional: Lot number of FLUMIST added. Start date of event and state date of FLUMIST updated to 29-Nov-2013. Patient details added.
pt devel sz post vax;pt was examined in ER but not hospitalized & is being observed;